Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Exchange Rate Effect (2020 - 2025)

ImmunityBio (IBRX) has disclosed Exchange Rate Effect for 6 consecutive years, with $5000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 171.43% to $5000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $15000.0, a 165.22% increase, with the full-year FY2025 number at $15000.0, up 165.22% from a year prior.
  • Exchange Rate Effect was $5000.0 for Q4 2025 at ImmunityBio, up from -$56000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $255000.0 in Q2 2022 to a low of -$254000.0 in Q1 2023.
  • A 5-year average of $1600.0 and a median of $2000.0 in 2023 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: surged 1200.0% in 2024, then crashed 609.09% in 2025.
  • ImmunityBio's Exchange Rate Effect stood at $65000.0 in 2021, then surged by 147.69% to $161000.0 in 2022, then tumbled by 116.77% to -$27000.0 in 2023, then soared by 74.07% to -$7000.0 in 2024, then surged by 171.43% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBRX's Exchange Rate Effect are $5000.0 (Q4 2025), -$56000.0 (Q3 2025), and $76000.0 (Q2 2025).